Across TCGA pan-cancer cohorts, RPS26P4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS26P4’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS26P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P4 is over-expressed in tumor.

KIRC and HNSC are the cancer types where RPS26P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	+0.059	.029	3	view →
HNSC	Male	II,III,IV	+0.058	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPS26P4 RNA expression & survival · all RPS26P4 data types